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Abstract
Purpose: The objectives of the work presented in this paper were to (1) imple-
ment a robust-optimization method for deliverable mixed-beam radiotherapy
(MBRT) plans within a previously developed MBRT planning framework; (2) per-
form an experimental validation of the delivery of robust-optimized MBRT plans;
and (3) compare PTV-based and robust-optimized MBRT plans in terms of tar-
get dose robustness and organs at risk (OAR) sparing for clinical head and neck
and brain patient cases.
Methods: A robust-optimization method, which accounts for translational setup
errors, was implemented within a previously developed treatment planning
framework for MBRT. The framework uses a hybrid direct aperture optimization
method combining column generation and simulated annealing. A robust plan
was developed and then delivered to an anthropomorphic head phantom using
the Developer Mode of a TrueBeam linac. Planar dose distributions were mea-
sured and compared to the planned dose. Robust-optimized and PTV-based
plans were developed for three clinical patient cases consisting of two head
and neck cases and one brain case. The plans were compared in terms of the
robustness to 5 mm shifts of the target volume dose as well as in terms of OAR
sparing.
Results: Using a gamma criterion of 3%/2 mm and a dose threshold of 10%,the
agreement between film measurements and dose calculations was better than
97.7% for the total plan and better than 95.5% for the electron component of the
plan.For the two head and neck patient cases, the average clinical target volume
(CTV) dose homogeneity index (V95%–V107%) over all the considered setup
error scenarios was on average 19% lower for the PTV-based plans and it had
a larger standard deviation. The robust-optimized plans achieved, on average,
a 20% reduction in the OAR doses compared to the PTV-based plans. For the
brain patient case, the CTV dose homogeneity index was similar for the two
plans,while the OAR doses were 22% lower,on average,for the robust-optimized
plan.No clear trend in terms of electron contributions was found across the three
patient cases, although robust-optimized plans tended toward higher electron
beam energies.
Conclusions: A framework for robust optimization of deliverable MBRT plans
has been developed and validated. PTV-based MBRT were found to not be
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2 HYBRID DIRECT APERTURE OPTIMIZATION APPROACH FOR MBRT
robust to setup errors, while the dose delivered by the robust-optimized plans
were clinically acceptable for all considered error scenarios and had better OAR
sparing.This study shows that the robust optimization is a promising alternative
to conventional PTV margins for MBRT.
KEYWORDS
mixed-beam radiation therapy, modulated electron radiation therapy, robust optimization, treatment
planning
1 INTRODUCTION
Mixed-beam radiotherapy (MBRT) refers to the com-
bination of intensity-modulated photon beams with
intensity- and energy-modulated electron beams. By
exploiting the advantageous dosimetric properties of
both modalities, specifically the steep lateral penumbra
of photon beams and the rapid distal falloff of electron
beams, MBRT plans can achieve a comparable target
coverage to photon-only intensity modulated radiation
therapy or volumetric modulated arc therapy (VMAT)
while reducing the integral dose and dose to organs at
risk (OARs).1–8
One of the challenges to the delivery of MBRT plans
is the need to collimate the electron beams close to the
patient surface to minimize in-air beam scattering. The
delivery of multiple electron apertures requires a more
efficient collimation system than conventional electron
cutouts. Many of the earlier MBRT studies relied on a
custom electron multi-leaf collimator (MLC),9,10 however,
more recently the feasibility of using the photon MLC
with a shortened source-to-surface distance (SSD) has
been shown.11 The optimization of MBRT plans is also
challenging due to the increased degrees of freedom
resulting from the availability of multiple beam modal-
ities and energies. Earlier MBRT planning approaches
reduced these degrees of freedom for the plan optimiza-
tion by pre-selecting the electron beam energies based
on the target depth.4
Two recent publications7,8 addressed the limitations
mentioned above by developing direct aperture opti-
mization (DAO) methods that simultaneously consider
all the available photon and electron beams and ener-
gies. Both studies used the photon MLC to collimate the
electron beams at a shortened SSD. Mueller et al.6 also
verified the deliverability of MBRT plans combining non-
coplanar photon arcs with step and shoot electron aper-
tures using the Developer mode of a TrueBeam linac
(Varian Medical Systems, Palo Alto, CA). The gamma
passing rate for planar film measurements in an anthro-
pomorphic head phantom was better than 99.2%, using
a 2%/2 mm criteria.
Recently, Renaud et al.12 investigated the robustness
of MBRT plans using conventional PTV margins to
translational setup errors. They demonstrated that for
certain error scenarios either the clinical target volume
(CTV) dose coverage was compromised or that hot
spots could occur resulting in a clinically unacceptable
dose distribution. Using a previously developed col-
umn generation method for MBRT optimization,8 they
implemented robust-optimization approaches based
on both the stochastic and minimax methods.13 These
approaches account for uncertainties in the optimization
variables by minimizing either the expectation value
or the maximum (worst case) value of the objective
function, evaluated over all considered error scenarios.
When evaluated under the same setup error scenarios
as the PTV-based plans, the robust-optimized plans
were able to maintain the CTV coverage and homo-
geneity. They also noted that the robust-optimized plans
had better OAR sparing compared to the PTV-based
plans. A comparison of the electron and photon contri-
butions of the PTV-based and robust-optimized plans
revealed an increase in the electron dose contribution for
robust-optimized plans. A preference for higher electron
energies was also noted in the robust-optimized plans.
A limitation of the above-mentioned study is that
they used a beamlet-based optimization, which does
not account for the influence of the MLC. Therefore, the
optimized dose may not accurately predict the deliv-
ered dose and delivered plan quality may be degraded.
The accuracy of the plan delivery was not verified in
this study. Furthermore, the authors compared robust-
optimized and PTV-based plans for chest wall and soft
tissue sarcoma cases only. Previous comparison of
MBRT and VMAT7 plans have demonstrated the suit-
ability of MBRT for other sites, such as head and neck.
Our group recently developed a hybrid DAO
approach14 for MBRT which uses both column-
generation and simulated annealing to optimize
deliverable plans collimated using the photon MLC.
The motivation to combine column generation with
simulated annealing is to exploit the advantages of both
approaches in order to obtain a faster convergence of
the objective function value with number of apertures
as well as to obtain a better plan quality. Implementing
simulated annealing in the hybrid DAO process allows
the possibility to further optimize aperture shapes after
they have been determined by the column generation
step. On the other hand, the column generation is more
computationally efficient and does not require the aper-
tures for each field to be predefined. A comparison of
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F IGURE 1 Robust mixed-beam radiotherapy (MBRT) planning process. The details of each step are described in the text below. The steps
within the hybrid direct aperture optimization (DAO) process are repeated until a user-specified number of apertures have been added
the performance of this hybrid DAO algorithm against
column generation alone is the subject of a forthcoming
paper.
The objectives of the work presented in this paper
were as follows: (1) implement a robust-optimization
method for deliverable MBRT plans using this hybrid
DAO framework; (2) perform an experimental validation
of the delivery of robust-optimized MBRT plans; and (3)
compare PTV-based and robust-optimized MBRT plans
in terms of target dose robustness and OAR sparing for
clinical head and neck and brain cases.
2 MATERIALS AND METHODS
2.1 Robust-optimization framework
The robust-optimization method was implemented
within a previously developed treatment planning pro-
cess for MBRT.14 Figure 1 shows an overview of the
components of the treatment planning process which
are described in the following paragraphs.The output of
this process is a set of apertures, and their associated
monitor units (MUs), defining a step-and-shoot MBRT
plan.
The robust MBRT planning process begins with
importing the CT images and contours into a research
version of the Eclipse treatment planning system (ver-
sion 15.6, Varian Medical Systems, Palo Alto, CA). This
is followed by defining the electron and photon fields. It
is important to note that for each electron beam direc-
tion there are multiple energies available (6, 9, 12, 15,
18, and 22 MeV). Hereafter, an electron “field” refers to a
unique beam direction and energy combination.
In the next step, a beamlet dose calculation is per-
formed for each field using the research Eclipse inter-
faced Swiss Monte Carlo Plan15 (SMCP) system. The
beamlet dose calculation uses pre-calculated phase
space files which are divided into beamlet-specific
phase space files using a 5 × 5 mm2 grid size defined
at the isocenter plane. For photon beams, these phase
space files are obtained from a VMC++16 simulation
of the linac head with the MLC and jaws fully retracted.
For electron beams, the phase space files are obtained
using a multiple source model17 which accounts for the
jaws and all upstream components. VMC++ is used
for the photon beamlet dose calculation in the patient
geometry while for the electron beams the macro Monte
Carlo algorithm18–20 is used. To model the dosimetric
impact of different setup error scenarios, in the parame-
ters for the beamlet dose calculation the user can spec-
ify both systematic and random translational shifts along
the three principal axes. Only systematic shifts were
investigated in this work and were modeled by applying
the same isocenter shift for each incident particle. The
output of the beamlet dose calculation is a complete set
of beamlets for each user-specified error scenario plus
the “nominal” (no error) scenario.
These beamlet dose distributions are then used as
inputs to a hybrid DAO process which uses both column
generation and simulated annealing. The optimizer
treats the photon and electron apertures equally and
the final selection of which modality and energy to add
is based on dosimetric characteristics. Starting from an
empty aperture pool, the following process is repeated
until a user-defined number of apertures have been
generated. At the beginning of each iteration, a set of
promising apertures are selected from among all the
defined fields based on their “price,”which is determined
by the gradient of the objective function with respect
to aperture weight21 (pricing). In this work, we used a
scheme where the most promising aperture is selected
for each photon and electron field. Each of the promis-
ing apertures is separately added to a copy of the
current aperture pool and the following steps are then
performed on each aperture pool. After the addition of
4 HYBRID DIRECT APERTURE OPTIMIZATION APPROACH FOR MBRT
a new aperture to a given pool, a deterministic weight
optimization is performed followed by the removal of
any apertures with zero weight. A further refinement
of the aperture weights and shapes is then performed
using simulated annealing. This is followed by a second
deterministic weight optimization. Afterward, the aper-
ture pool that has the lowest objective function value is
selected and the other pools are deleted (decision). If
the total number of apertures in the remaining pool is
equal to the user defined number of apertures, then the
hybrid DAO process is terminated. Otherwise, another
iteration of the process, starting with the pricing step, is
started. Throughout the hybrid DAO process, to enforce
robustness against setup errors the pricing, simulated
annealing and deterministic weight optimization steps
were all modified to use the expectation value of the
objective function calculated for the nominal and all
user-specified setup error scenarios.
Following the hybrid DAO process, the dose distribu-
tions from the final aperture pool are re-calculated using
SMCP, this time including the influence of the jaws and
MLC. For the electron beams, the same multiple source
model is used to model the jaws and all upstream com-
ponents and an in-house Monte Carlo algorithm, PIN,22
is used to model the transport through the MLC. For the
photon beams, VMC++ is used to model the transport
through the MLC and jaws. The transport in the patient
geometry is modeled using the same algorithms as for
the beamlet dose calculations. Similar to the beamlet
dose calculation, isocenter shifts corresponding to the
modeled setup error scenarios were simulated and a
complete set of aperture dose distributions are calcu-
lated for each user-specified setup error scenario plus
the nominal scenario. These aperture dose distributions
are used as inputs to a final robust deterministic weight
optimization, whose purpose is to correct for plan dete-
rioration due to discrepancies between the beamlet and
final dose calculations. The aperture dose distributions
corresponding to each scenario are then summed. The
mean statistical uncertainty for the total dose distribution
is nominally 0.5%. The dose distributions are then nor-
malized according to the user specification and imported
into eclipse for plan evaluation.
2.2 Experimental validation
An artificial brain tumor case was created on the CT
image of an anthropomorphic head phantom (Alder-
son Radiation Therapy Phantom, Radiology Support
Devices).The CTV contours of a clinical brain case were
manually copied while the relevant OARs were delin-
eated by an experienced radiation oncologist. The pre-
scribed dose was 60 Gy in 30 fractions.
Three electron beam directions,with SSDs of 67.9 cm,
72.3 cm, and 82.3 cm, were used as shown in Figure 2.
F IGURE 2 Electron beam arrangements for the artificial brain
case on the Alderson head phantom. The location of each beam
isocenter is indicated by yellow circle. The clinical target volume
(CTV) is shown in red
The electron beam SSD was aimed to be as close to
70 cm as possible to minimize the in-air scattering while
avoiding collision between the gantry and the patient or
couch. Six electron beams were defined for each of the
three beam directions,corresponding to energies of 6,9,
12,15,18,and 22 MeV.In addition,seven isocentric 6 MV
photon beams were defined. The SMCP beamlet and
aperture dose calculations were set to calculate dose to
water to be compatible with the dose measurements.
A robust plan comprised of 60 apertures was opti-
mized on the head phantom case considering a system-
atic 5 mm translational setup error along the superior-
inferior (SI), anterior-posterior (AP), and left-right (LR)
directions. The equal importance was applied to the
nominal and each error scenario when calculating
the expectation value of the objective function during
the plan optimization. The target volume was the CTV
and the plan was normalized so that the D50% of the
CTV was equal to 60 Gy. Target volume and OAR doses
were evaluated on the nominal and six error scenarios
and compared to institutional planning guidelines. The
plan was deemed acceptable if dose-volume tolerances
were satisfied for all seven scenarios.
Delivery of the robust plan was carried out using the
Developer mode of a Varian TrueBeam linac (Varian
Medical Systems, Palo Alto, CA). The head phantom
was secured to the linac couch with a thermoplastic
mask. The phantom setup was verified by acquiring two
orthogonal kV images and performing an automated
2D–3D alignment to the planning CT based on bony
anatomy.Only translational setup errors were corrected,
but it was verified that the rotational errors were less
than 1◦. Gafchromic EBT3 film (Ashland Advanced
Materials, Bridgewater, NJ) was placed between the
first and second, and the second and third slices of the
head phantom. The film was cut to conform to the outer
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F IGURE 3 Electron beam arrangements for three clinical cases. The location of each beam isocenter is indicated by yellow circle. The
clinical target volume (CTV) for each case is shown in red
contour of the phantom. Multiple film irradiations were
performed for the delivery of the total plan (photon and
electron apertures), photon apertures only and electron
apertures only. Each irradiation was performed with and
without a 5 mm couch shift (i.e., nominal and one error
scenario). Additionally, the dose from the total plan was
measured with and without a 5 mm couch shift in the
lateral direction in another measurement slice. Shifts
along the inferior and lateral directions were selected
based on the observed changes in the calculated
dose distributions on the measurement slices for these
scenarios.
Films were scanned 24 h post-irradiation using
an Epson 10000XL scanner and the FilmQA Pro
software (Ashland Advanced Materials, Bridgewater,
NJ) following a triple channel dosimetry protocol.23 Cor-
rections for lateral scanning artefacts24 were applied.
The film images and corresponding 2D dose distribu-
tions exported from Eclipse were manually aligned using
the two phantom support rod holes. The film and dose
distribution agreement was assessed using gamma
analysis with a 3%/2 mm criterion and a 10% dose
threshold, following the recommendations of AAPM
Task Group 218.25
2.3 Planning study
Robust-optimized and PTV-based MBRT plans were
designed on three clinical cases consisting of two head
and neck cases (dose prescription: D95% = 50 Gy in
25 fractions) and one brain case (dose prescription:
D50% = 60 Gy in 30 fractions). For the robust-optimized
plans, the dose prescription was applied to the CTV,
while for the PTV-based plans it was applied to the PTV.
Both the robust and PTV-based plans used identical
beam arrangements. The electron beam directions spe-
cific to each case are shown in Figure 3. These beam
directions are selected based on the proximity of the tar-
get volume to the patient surface as well as providing an
approximately normal incidence of the electron beam
on the patient’s surface. To avoid introducing any bias
due to photon beam angle selection,an identical photon
beam arrangement of nine equally angular spaced 6 MV
isocentric photon beams were used for all three cases.
Dose to medium calculation was used for both beamlet
and final aperture dose calculations.
The PTV-based plans used a 5 mm isotropic CTV to
PTV margin.The PTV was cropped 3 mm from the outer
body contour following institutional guidelines. For any
OARs that had planning at risk volumes (PRVs) spec-
ified in the original clinical plan, a 5 mm margin was
also used to generate the PRV structure. A normal tis-
sue structure was constructed of all tissue exclusive
of the PTV and OARs. Plan acceptability was evalu-
ated according to institutional planning guidelines on the
nominal scenario only. The target volume coverage was
evaluated on the PTV, while for OARs that had PRVs,
the doses to those PRV structures were compared to
clinical tolerances.
The robust-optimized plans were generated using the
CTV as the target volume and no PRV structures. For
these plans, the normal tissue structure was constructed
of all tissue exclusive of the CTV and OARs.Plans were
optimized considering systematic 5 mm setup errors
in the SI, AP, and LR directions. The equal importance
was applied to the nominal and each error scenario
when calculating the expectation value of the objec-
tive function.Plan acceptability was determined by com-
paring CTV and OAR doses to institutional planning
guidelines on both the nominal and all six error sce-
narios. The homogeneity of the dose in the CTV was
assessed using the percentage of the CTV receiving
greater than 95% and less than 107% of the prescribed
dose: HI95/107 = V95% − V107%.26
The plan quality for both the PTV-based and robust-
optimized plans was found to depend on the num-
ber of apertures. Therefore, for each patient case, the
plans were run with up to 200 apertures to deter-
mine the required number of apertures for convergence.
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TABLE 1 Results of gamma comparison (3%/2 mm, 10%
threshold) of film measurements and dose calculation for robust plan
delivery to head phantom
Gamma passing rate









With 5 mm couch
shift
1 Total 98.1% Inferior 98.7%
1 Photon 98.7% Inferior 98.8%
1 Electron 98.0% Inferior 95.5%
2 Total 97.7% Lateral 97.7%
The resulting PTV-based and robust-optimized plans
were then compared in terms of target volume coverage
and OAR sparing on all seven scenarios.
3 RESULTS
3.1 Experimental validation
The results of the gamma comparison of the dose mea-
surements and calculations in the head phantom are
shown in Table 1. Delivery of the total plan required
6 min 23 s. A total of eight film measurements were
compared with the corresponding dose calculations.
When comparing the total plan dose, the agreement was
97.7% or better. The worst agreement was for the elec-
tron apertures (95.5%),while the agreement for the pho-
ton apertures was 98.7% or better. Figure 4 shows a
comparison of measured and calculated isodoses for
the same measurement slice, with and without a 5 mm
lateral isocenter shift.
3.2 Planning study
3.2.1 Head and neck case 1
Figure 5 shows a comparison of isodose distributions
and dose–volume histograms (DVHs) for the robust-
optimized and PTV-based MBRT plans for the first head
and neck case. One hundred fifty apertures were used
for both plans. The 37.5 Gy and 47.5 Gy (75% and 95%
of the prescription dose,respectively) isodoses are more
conformal to the CTV in the robust plan than in the PTV
plan. Furthermore, the CTV DVHs for all scenarios are
more closely spaced for the robust plan indicating that
the CTV coverage is less sensitive to setup errors than
the PTV plan.
The CTV coverage for all six error scenarios was clin-
ically acceptable for both plans, however, for the PTV-
based plan, in five of the six error scenarios the D5%
of the CTV exceeded the clinical tolerance. Compared
to the CTV, the OAR DVHs show a greater variation
with setup errors. For the pharyngeal constrictors and
the thyroid, the largest variations occurred for shifts
along the left/right direction, while for the oral cavity and
ipsilateral parotid gland the largest variation occurred
with shifts along the superior/inferior direction. For the
PTV-based plan, the DVHs for the contralateral carotid
artery show large deviations from the DVH for the corre-
sponding PRV volume (blue dashed line) on the nominal
case. The clinical tolerances for the carotid artery were
exceeded in three out of the six error scenarios for the
PTV-based plan.
The dose–volume metrics for the nominal and six
setup errors scenarios, for both the robust-optimized
and PTV-based plans are summarized in Table 2.
The robust-optimized plan has a higher average CTV
dose homogeneity index (HI95/107),94.1% versus 67.5%,
and its standard deviation is smaller compared to the
F IGURE 4 Comparison of measured (thin lines) and calculated (thick lines) isodose distributions for the total plan dose of the robust plan
in measurement slice 2. Note that the “hole” located in the lower left quadrant of the isodose distribution corresponds to the location of the
Alderson phantom supporting rod and therefore no dose is measured at this location
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F IGURE 5 Left: Isodose distributions on nominal scenario for robust-optimized (top row) and PTV-based (bottom row) mixed-beam
radiotherapy (MBRT) plans for the first head and neck patient. Clinical target volume (CTV) is shown in red, contralateral carotid artery in pink
and pharyngeal constrictors in yellow. Center/Right: Dose–volume histograms (DVHs) for nominal scenario (thick lines) and six setup error
scenarios (thin lines). DVHs, for nominal scenario, for any PTV or planning at risk volume (PRV) structures are shown as thick dashed lines
TABLE 2 Comparison of dose–volume metrics (average ± SD) for nominal and six setup error scenarios for the two head and neck clinical
cases. The larynx structure was not contoured on Patient 1
H&N Patient 1 H&N Patient 2
Robust PTV Robust PTV
CTV HI95/107 (%) 94.1 ± 3.1 67.5 ± 8.4 90.7 ± 2.1 80.0 ± 13.2
Contralateral carotid artery, Dmean (Gy) 5.4 ± 0.6 6.9 ± 0.9 5.9 ± 0.6 6.8 ± 0.9
Contralateral carotid artery, D2% (Gy) 15.0 ± 2.5 20.9 ± 4.5 20.4 ± 5.5 25.6 ± 6.4
Ipsilateral parotid gland, Dmean (Gy) 19.3 ± 2.8 26.0 ± 2.9 19.0 ± 3.8 27.5 ± 4.0
Contralateral parotid gland, Dmean (Gy) 3.5 ± 0.4 4.9 ± 0.5 7.0 ± 0.4 7.7 ± 0.4
Glottic/supraglottic larynx, D2% (Gy) – – 35.5 ± 5.5 47.7 ± 4.7
Thyroid, Dmean (Gy) 25.3 ± 2.5 28.7 ± 2.0 20.4 ± 2.3 25.1 ± 2.0
Pharyngeal constrictors, Dmean (Gy) 28.4 ± 1.5 31.0 ± 1.6 30.7 ± 2.0 36.1 ± 2.2
Oral cavity, Dmean (Gy) 13.1 ± 1.9 15.9 ± 2.0 16.3 ± 1.2 20.1 ± 1.6
Normal tissue, V10% 14.7 ± 0.6 18.7 ± 0.7 14.3 ± 0.4 17.6 ± 0.5
Total MU 744.6 763.5 876.7 842.1
Electron MU fraction (%) 22.9 22.5 19.5 22.6
Electron CTV Dmean fraction (%) 35.6 35.9 21.5 34.1
Note: Bold values indicate the "best" value between the two plans for each patient.
Abbreviation: CTV, clinical target volume; MU, monitor unit.
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F IGURE 6 Comparison of electron (a,b) and photon (c,d) dose contribution for robust-optimized (left column) and PTV-based (right
column) mixed-beam radiotherapy (MBRT) plans. Electron, photon, and total dose profiles (e,f) for the directions indicated by the white arrows in
(b). Solid lines indicate the total dose, thick dashed lines are electron dose, and fine dashed lines are photon dose. Vertical dashed lines indicate
the extent of the clinical target volume (CTV)
PTV-based plan. All of the OAR dose metrics are lower,
by 20.4% on average, for the robust-optimized plan than
for the PTV-based plan.The normal tissue V10% was 4%
lower for the robust plan. The number of MUs as well as
the electron contributions in terms of MUs and mean
CTV dose are similar for both plans.
Figure 6 shows the dose distributions from the elec-
tron apertures or photon apertures only for the two
plans. The dose distributions for both modalities are
more uniform for the robust plan than for the PTV plan.
Dose profiles along the left/right direction are included
for two different positions, corresponding to the maxi-
mum and minimum electron dose contribution for the
PTV-based plan. The relative electron dose contribu-
tions at these different locations vary, but the range of
the electron dose profile in Figure 6e appears to be
greater for the robust plan than for the PTV-based plan.
This observation is consistent with the finding that the
MU-weighted mean energy of the robust plan is 16.0
MeV and the beam energy with the most MUs is 22 MeV,
while the corresponding values for the PTV-based plan
are 15.5 MeV and 12 MeV. Comparing the photon dose
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F IGURE 7 Left: Isodose distributions on nominal scenario for robust-optimized (top row) and PTV-based (bottom row) mixed-beam
radiotherapy (MBRT) plans for the second head and neck patient. Clinical target volume (CTV) is shown in red, contralateral carotid artery in
pink and larynx in yellow. Center/Right: Dose–volume histograms (DVHs) for nominal scenario (thick lines) and six setup error scenarios (thin
lines). DVHs, for nominal scenario, for any PTV or planning at risk volume (PRV) structures are shown as thick dashed lines
profiles in Figure 6f , it appears that the tighter distal mar-
gin for the robust plan is determined mainly by the pho-
ton contribution of this plan.
3.2.2 Head and neck case 2
Figure 7 shows the isodose distributions and DVHs
for second head and neck case which also used 150
apertures for both plans. Once again, the isodoses are
more conformal to the CTV for the robust plan than for
the PTV-based plan. For the PTV-based plan, the CTV
DVHs vary noticeable across the six error scenarios and
deviate from the nominal PTV DVH (red dashed line).
The largest deviation corresponds to a 5 mm shift in
the superior direction. For this case, the CTV D95% was
below the clinical tolerance. The CTV D5% as well as
some of the carotid plan criteria were exceeded in two
of the tested error scenarios. The dose–volume met-
rics in Table 2 show that similar to the first head and
neck patient case, the average CTV dose homogene-
ity was lower and had a larger standard deviation for the
PTV-based plan (80.0± 13.2%) compared to the robust-
optimized plan (90.7 ± 2.1%). Table 2 also shows that
the OAR doses were consistently lower, by on average
19%, for the robust-optimized plan and the normal tis-
sue V10% was 3.3% lower.The fraction of the CTV mean
dose contributed by the electron apertures was lower
(21.5% vs. 34.1%) for the robust plan compared to the
PTV-based plan.
Figure 8 shows the photon and electron contributions
for both plans.Similar to the first head and neck case,the
electron dose distribution is more uniform for the robust
plan compared to the PTV-based plan. A lateral dose
profile at the location of the maximum electron dose
contribution in the PTV-based plan shows a reduced
electron dose for the robust-plan as well as a tighter
distal margin for the photon dose profile. Similar trends
were noted for dose profiles at other locations.The mean
MU-weighted energy of the robust plan is 17.8 MeV and
the beam energy with most MUs is 22 MeV,while the cor-
responding values for the PTV-based plan are 15.6 MeV
and 15 MeV.
3.2.3 Brain case
Figure 9 shows the isodose distributions and DVHs for
the brain case. Both the robust and PTV plans used
80 apertures. Table 3 summarizes the relevant dose–
volume metrics for these plans. The CTV dose homo-
geneity index was almost identical for both plans, while
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F IGURE 8 Comparison of electron (a,b) and photon (c,d) dose contributions for second head and neck case; (e) electron (thick dashed
line), photon (thin dashed line) and total (solid lines) dose profiles for the direction indicated by the white arrow in (b). Vertical dashed lines
indicate the extent of the clinical target volume (CTV)
the OAR doses were 21.7% lower, on average, for the
robust plan. The normal tissue V10% was 4% lower for
the robust plan compared to the PTV plan.Clinical dose–
volume criteria were respected for all setup error scenar-
ios for both plans.
The electron dose contribution for the robust plan is
approximately 2.5 times greater than for the PTV plan.
Figure 10 compares the electron and photon dose con-
tribution of the two plans.For this case, the electron dose
contribution for the robust plan is less uniform than for
the PTV-based plan. The robust plan has an increased
electron dose contribution at the superior and inferior
borders of the CTV. The enhancement on the superior
border is inside the skull. This is evident in the elec-
tron dose profile for the robust plan (red dashed line)
in Figure 10e. Another observation from Figure 10e,f
is that the photon dose contribution of the robust plan
contributes to the smaller margin on the inferior side of
the CTV. The mean MU-weighted energy of the PTV-
based plan for the brain case was 20.6 MeV and the
beam energy with the most MUs was 22 MeV, while the
robust plan used only 22 MeV beams.
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F IGURE 9 Left: Isodose distributions on nominal scenario for robust-optimized (top row) and PTV-based (bottom row) mixed-beam
radiotherapy (MBRT) plans for the brain patient case. The clinical target volume (CTV) is shown in red. Center/Right: Dose–volume histograms
(DVHs) for nominal scenario (thick lines) and six setup error scenarios (thin lines). DVHs, for nominal scenario, for any PTV or planning at risk
volume (PRV) structures are shown as thick dashed lines
TABLE 3 Comparison of dosimetric values (average ± SD)
across nominal and six setup error scenarios for the brain case
Robust PTV
Number of apertures 60 60
CTV HI95/107 (%) 99.7 ± 0.3 99.6 ±0.3
Chiasm, D2% (Gy) 41.6 ± 4.9 44.7 ± 3.8
Brainstem, D2% (Gy) 36.4 ± 2.8 42.6 ± 3.6
Ipsilateral optic nerve, D2% (Gy) 42.3 ± 5.4 47.9 ± 2.0
Contralateral optic nerve, D2% (Gy) 15.0 ± 2.8 23.1 ± 2.3
Ipsilateral lacrimal gland, Dmean (Gy) 10.7 ± 2.3 17.6 ± 3.2
Contralateral lacrimal gland, Dmean (Gy) 3.9 ± 0.5 4.4 ± 0.6
Ipsilateral eye, D2% (Gy) 18.3 ± 5.9 27.2 ± 6.1
Contralateral eye, D2% (Gy) 7.9 ± 1.9 10.1 ± 2.7
Normal tissue, V10% (%) 14.9 ± 0.4 18.9 ± 0.5
Total MU 431.7 434.3
Electron MU fraction (%) 16.2 7.2
Electron CTV Dmean fraction (%) 31.6 12.8
Note: Bolded values indicate the “best” value between the two plans.
Abbreviation: CTV, clinical target volume; MU, monitor unit.
4 DISCUSSION
In this paper, we presented the development, exper-
imental validation, and application of a robust
hybrid DAO approach for MBRT planning. Similar to
Renaud et al.,12 we investigated robustness to trans-
lational setup errors using the stochastic optimization
approach. However, our approach uses a combination
of simulated annealing and column generation, while
Renaud’s approach was based on column generation
only.
Compared to the previous experimental validation
of the delivery of (nonrobust) MBRT plans by Mueller
et al.,6 the agreement between film measurements and
dose calculations for our robust plans was slightly lower,
at 97.7% for 3%/2 mm criterion, but still acceptable
according to the recommendations of AAPM Task
Group 218.25 The photon component of the MBRT
plans previously validated by Mueller et al. consisted of
non-coplanar arcs, while in the current study we used a
coplanar step-and-shoot delivery for photons and elec-
trons. We also presented validation results for photon
and electron apertures separately, while previous work
compared only the total dose distribution. The agree-
ment between calculations and measurements was
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F IGURE 10 Comparison of electron (a,b) and photon (c,d) dose contributions for the brain case. Electron, photon, and total dose profiles
(e,f) for the direction indicated by the white arrows in (a) and (d). Solid lines indicate the total dose, thick dashed lines are electron dose, and fine
dashed lines are photon dose. Vertical dashed lines indicate the extent of the clinical target volume (CTV)
found to be lower for the electron apertures than for the
photon apertures. This could be attributed to limitations
of the electron beam model used in dose calculations as
well as a higher sensitivity of electron beams to experi-
mental uncertainties such as air gaps.27 The agreement
between calculations and measurements was similar
for the shifted and unshifted cases which gives us con-
fidence that setup errors are correctly modeled. Overall,
these experiments demonstrate the feasibility and accu-
racy of the delivery of MBRT plans using the photon
MLC and a shortened SSD. However, before clinical
implementation, a more comprehensive evaluation of
the delivery accuracy of robust MBRT plans is needed.
Heng et al.28 recently reported initial results of a patient-
specific MBRT QA process based on ion chamber and
film dosimetry. Our group has also developed a patient-
specific QA procedure for MBRT using log file based
dose calculation and EPID measurements.
A comparison of robust-optimized and PTV-based
plans was carried out for two head and neck and one
brain clinical case. Similar to Renaud et al.,12 we found
that PTV-based MBRT plans were not robust to trans-
lational setup errors and that robust-optimized plan
had improved OAR sparing. We also found a trend of
increased electron beam energies in the robust plans.
However, while Renaud et al. noted an increase in the
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electron dose contribution for the robust plans compared
to the PTV-based plans we did not find a consistent
trend in our plans. The electron contributions were sim-
ilar for both plans for the head and neck cases, while
for the brain case the electron contribution in the robust
plan was more than double that for the PTV-based plan.
Also, the dose distribution from the electron apertures
of the robust plan was less uniform for the brain case
compared to the head and neck cases. The enhance-
ment at the superior side of the CTV coincides with
the skull, where the increased stopping power in bone
is expected to result in a dose enhancement. However,
the dose enhancement at the inferior side of the CTV
does not coincide with bone. Therefore, we hypothe-
size that in the robust plan the optimizer is increasing
the fluence at the edges of the target volume to com-
pensate for the setup errors. This is consistent with the
edge enhancement noted by Unkelbach and Oelfke29
when determining the ideal fluence profiles accounting
for target volume displacements in an idealized geom-
etry. Compared to the head and neck cases, there are
fewer dose-limiting OARs surrounding the target vol-
ume for the brain case which might explain why the
edge enhancement was not observed for the head and
neck cases. It should be noted that both Renaud’s and
our study used a limited number of patient cases and
a larger number of cases is needed to clearly identify
trends and the factors that influence them.
5 CONCLUSIONS
A framework for robust optimization of deliverable
MBRT plans has been developed and validated. Plans
optimized with our robust framework were compared
with PTV-based plans on two head and neck and one
brain case in terms of robustness of target volume
dose to setup errors as well as OAR sparing. PTV-
based MBRT were found to not be robust to setup
errors, while the dose delivered by the robust-optimized
plans were clinically acceptable for all error scenarios
and had better OAR sparing. This study shows that
the robust optimization is a promising alternative to
conventional PTV margins for MBRT.
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